Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG40893

EIF1AY Knockout HAP1 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone Marrow

  • Disease:

    Chronic myeloid leukemia

The EIF1AY Knockout HAP1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population featuring disruption of the Y-linked EIF1AY gene in the near-haploid HAP1 cell line. This loss-of-function model is designed for investigating translation initiation fidelity and protein synthesis regulation. EIF1AY encodes a translation initiation factor that interacts with eIF1, eIF3, and the 40S ribosomal subunit, and is regulated by mTORC1 signaling. Knockout cells are valuable for studying Y chromosome gene function, translation dysregulation in cancer, and male infertility. Typical assays include western blotting, polysome profiling, and flow cytometry for protein synthesis rates.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HAP1

    Sex of Donor

    Male

    Age

    40 years

    Derived From Site

    Bone marrow

    Gene Name

    EIF1AY

    Gene Identifier

    NCBI Gene ID 9086

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    IMDM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The EIF1AY Knockout HAP1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the haploid HAP1 cell line, featuring disruption of the Y-linked eukaryotic translation initiation factor 1A gene (EIF1AY). This heterogeneous pool provides a robust loss-of-function model for studying translation initiation and protein synthesis, avoiding clonal selection biases and ensuring broad representation of editing events. The polyclonal format is ideal for functional genomics, high-throughput screens, and pathway analysis where reproducibility across diverse genetic backgrounds is critical.

HAP1 is a near-haploid, fibroblast-like cell line originally isolated from a male chronic myeloid leukemia patient. Its karyotype is predominantly haploid, with only chromosome 8 and a segment of chromosome 15 present in diploid form, which ensures that most genes, including the Y-linked EIF1AY, exist in a single copy. This genetic simplicity yields unambiguous loss-of-function phenotypes and makes HAP1 cells a standard platform for haploid genetic screens, drug target validation, and quantitative gene-dosage studies. The lineage exhibits stable growth and is compatible with a wide array of biochemical and cell-based assays.

EIF1AY encodes the Y-linked isoform of eukaryotic translation initiation factor 1A, a critical factor ensuring start codon fidelity during 43S preinitiation complex scanning. It cooperates with eIF1 to discriminate AUG from near-cognate codons, interacting directly with eIF5, eIF3, eIF2, and the 40S ribosomal subunit. Its activity is regulated by mTORC1 kinase in response to nutrient availability and growth factors, integrating translational control with metabolic cues. Downstream, EIF1AY modulates global protein synthesis rates and the assembly of initiation complexes, linking to the eIF4F cap-binding complex via mTOR/4E-BP1/eIF4E signaling. This positions EIF1AY as a central node connecting nutrient sensing to translation initiation fidelity.

Disruption of EIF1AY in the haploid HAP1 background generates a clean loss-of-function model for investigating Y chromosome gene function and male-specific translational regulation. Because HAP1 cells contain a single copy of EIF1AY, knockout eliminates all functional protein without diploid compensation. The model is particularly relevant for studying translational dysregulation in cancers with hyperactive mTORC1 signaling, and for exploring links to male infertility, where compromised start codon fidelity may affect spermatogenesis. The haploid state amplifies phenotypic consequences, enhancing sensitivity in polysome profiling and protein synthesis rate measurements.

Typical applications encompass characterization of start codon selection mechanisms, analysis of EIF1AY interaction networks, and dissection of mTORC1-dependent translation control. Suitable assays include western blotting for protein loss verification, RT-qPCR, polysome fractionation, luciferase reporter assays for initiation fidelity, ribosome footprinting for codon occupancy, and flow cytometry with OPP or puromycin labeling to quantify protein synthesis. These cells also support co-immunoprecipitation studies and high-content screens for translation modulators. For additional information, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)